Revenue Manipulation Casts a Shadow Over Medikabazaar’s Growth

- Medikabazaar, a B2B marketplace for medical supplies, is under scrutiny after a PwC forensic audit revealed discrepancies in revenue recognition. Co-founder Vivek Tiwari is expected to step down as CEO but will remain on the board. - The company, valued at $650 million, has raised $194 million to date. Its major investors include Creaegis, Lighthouse India, HealthQuad, Rebright, and Ackerman. - The board, led by Creaegis, found that Medikabazaar may have inflated its 2023-24 revenue by 60-65%. This prompted an external audit by PwC, which is ongoing. - Allegations suggest that Medikabazaar overstated revenues from its largest business segment, medical equipment sales, primarily through a partnership with China’s United Imaging. - If proven, the revenue manipulation could trigger clauses in the shareholder agreement, potentially costing Tiwari and co-founder Ketan Malkan a portion of their equity stakes. Source: The Arc

Soros

Stealth

2 months ago

Heard Zoplar is another startup in same space

Discover More

Curated from across

Indian Startups on

by DaringTrain

Stealth

2 months ago

Medikabazaar - Another B2B fraud found

Company was inflating GMV by 60%

Indian Startups on

by Spectator21

Freelancer

2 months ago

What is happening with Medikabazaar

Has anyone worked here? Heard they are good at some levels. This sounds concerning

Layoffs on

by Sooper42

Stealth

a year ago

Health care start-up shut shop after raising $25 million

The health-tech company raised $25 million in 2022. Now their operations are shut, website deactivated. They haven't paid their employees for over 3 months. They encouraged employees to resign and brought their count down from 2000 to 200. They even played a facade to showcase they were afloat by hiring people in Jan 2023, and moving to a larger office space. The employees allege the company had promised to clear the dues. This was backed by the Kalaari capital and others. What's happening with health tech?